LCT.AX
Living Cell Technologies Ltd
Price:
0.01
AUD
Volume:
1,378,040
Australia | Biotechnology
LCT.AX Relative Valuation
-213.5 %
Upside
As of 2025-07-03, the Relative Valuation of Living Cell Technologies Ltd (LCT.AX) is (0.01) AUD. This relative valuation is based on P/E multiples. With the latest stock price at 0.01 AUD, the upside of Living Cell Technologies Ltd based on Relative Valuation is -213.5%.
The range of the Relative Valuation is (0.01) - (0.01) AUD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 6.9x - 9.5x | 8.6x |
| Forward P/E multiples | 11.4x - 20.2x | 14.3x |
| Fair Price | (0.01) - (0.01) | (0.01) |
| Upside | -213.4% - -193.8% | -213.5% |
0.01 AUD
Stock Price
(0.01) AUD
Fair Price
| (AUD in millions except Fair Price) | |||
| Market Cap (AUD mil) | Trailing P/E | Forward P/E | |
| Living Cell Technologies Ltd | 21 | N/A | N/A |
| Clinuvel Pharmaceuticals Ltd | 501 | 12.9x | 14.3x |
| NeuroScientific Biopharmaceuticals Ltd | 10 | 8.6x | 43.6x |
| Industry median | 8.6x | 14.3x | |
| (*) Profit after tax | -2 | -2 | |
| Equity value | -18 | -30 | |
| (/) Outstanding shares | 1,636 | 1,636 | |
| Fair price | -0 | -0 | |